Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|March 28, 1996
Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-alpha synthesisT F Greten, B Sinha, C Haslberger, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1996
Synthesis of tumour necrosis factor-alpha in tissue culture of rat caecum: lack of suppression by phosphodiesterase inhibitors and prostanoidsT F Greten, J Moeller, H Feldmeier, et al.
Journal of Clinical Microbiology|September 1, 1994
Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infectionM Ruhnke, A Eigler, I Tennagen, et al.
Endoscopy|October 5, 2006
Vascular ectasia of the whole intestine as a cause of recurrent gastrointestinal bleeding after high-dose chemotherapyR Schmidmaier, I Bittmann, M Götzberger, et al.
European Journal of Pharmacology|February 26, 1997
Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agentsB Siegmund, A Eigler, J Moeller, et al.
Journal of Leukocyte Biology|February 20, 1998
Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF productionA Eigler, B Siegmund, U Emmerich, et al.
Antisense & Nucleic Acid Drug Development|January 1, 1996
Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotidesG Hartmann, A Krug, A Eigler, et al.
Research in Immunology|June 17, 1998
Nitric oxide downregulates tumour necrosis factor in mRNA in RAW 264.7 cellsB Sinha, A Eigler, K H Baumann, et al.
Leukemia Research|July 25, 1998
The hairy cell leukemia cell line Eskol spontaneously synthesizes tumor necrosis factor-alpha and nitric oxideA Eigler, K Waller-Fontaine, J Moeller, et al.
Cancer Research|August 28, 2001
Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccinesM Schnurr, P Galambos, C Scholz, et al.
Pageof 4